CDH17 and colorectal carcinoma: In contrast, our study analyzed CDH17 immunoexpression in multiple histological regions—tumor core, invasive front, lymphovascular emboli, and lymph node metastases—in 84 CRC cases selected for the presence of lymphovascular invasion.